Combine tirzepatide with a heart-healthy diet rich in omega-3 fatty acids, regular moderate exercise, and monitoring of blood pressure and lipids
Legal documents note that the original labels lacked warnings of severe side effects, from gastrointestinal issues to vision problems
Unlike GHK-Cu, which has decades of preclinical and some cosmetic data, AHK-Cus peptide-specific evidence is essentially one ex-vivo / in-vitro study [1] , and no study of any kind has injected it
If you've handled 2.5 mg without significant side effects, escalation is the standard next step
roughly 50-98 % of an administered dose is renally excreted unmetabolized, underscoring the low intrinsic toxicity
GIP agonism enhances insulin secretion in response to nutrients and appears to improve how peripheral tissues handle glucose, layering an additional incretin effect on top of GLP-1